BY Advocate.com Editors
August 30 2002 12:00 AM ET
Cancer drug shows promise in treating K.S.
Phase II human trials of Bristol-Myers Squibb's anticancer drug paclitaxel--already approved to treat some cases of breast, ovarian, and lung cancers under the brand name Taxol--have shown that the drug is effective in treating advanced AIDS-related Kaposi's sarcoma, AIDS Policy & Law reports. The medication appears most useful in treating K.S. in patients who have failed other chemotherapy agents. The drug was evaluated in 107 male patients with advanced K.S. who had failed at least one previous regimen of systemic chemotherapy. More than half of the patients experienced a complete or partial response to the drug. Additional data from the clinical trial is expected to be released later this year. Phase III trials are planned.
- Brokeback Mountain: The 10th Anniversary of a Gay Classic
- The Top 175 Essential Films of All Time for LGBT Viewers
- World Record Bodybuilder Comes Out as Trans
- 10 Things People Living With HIV Are Sick of Hearing
- Even the Rehearsal Footage From Madonna's Rebel Heart Tour Is Spellbinding
- WATCH: CIA Contractor Details Antigay Harassment by Colleagues in War Zone